We are live on ! Find out more
NVIV

InVivo Therapeutics Holdings Corp
NVIV

Delisted

NVIV was delisted on the 12th of February, 2024.

Back to rankings

19 hedge funds and large institutions have $1.09M invested in InVivo Therapeutics Holdings Corp in 2021 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

19% more funds holding

Funds holding: 16 → 19 (+3)

18% less capital invested

Capital invested by funds: $1.32M → $1.09M (-$236K)

Holders
19
Holders Change
+3
Holders Change %
+18.75%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
4
Reduced
1
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$148K
2
VF
Virtu Financial
New York
+$72.3K
3
Jane Street
Jane Street
New York
+$26.9K
4
Two Sigma Advisers
Two Sigma Advisers
New York
+$21.5K
5
Renaissance Technologies
Renaissance Technologies
New York
+$18K

Top Sellers

Rank Fund Capital Flow
1
TSS
Two Sigma Securities
New York
-$14.6K
2
TRCT
Tower Research Capital (TRC)
New York
-$8K
3
SWP
Stratos Wealth Partners
Ohio
-$7K
4
SPIA
Steward Partners Investment Advisory
New York
-$3K
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$396K – – –
Vanguard Group
2
Vanguard Group
Pennsylvania
$263K +$148K +10,313 +81%
Geode Capital Management
3
Geode Capital Management
Massachusetts
$126K – – –
State Street
4
State Street
Massachusetts
$100K – – –
VF
5
Virtu Financial
New York
$58K +$72.3K +5,040 New
Northern Trust
6
Northern Trust
Illinois
$32K – – –
Jane Street
7
Jane Street
New York
$21K +$26.9K +1,872 New
Two Sigma Advisers
8
Two Sigma Advisers
New York
$17K +$21.5K +1,496 New
Renaissance Technologies
9
Renaissance Technologies
New York
$14K +$18K +1,256 New
Morgan Stanley
10
Morgan Stanley
New York
$13K +$14 +1 +0.1%
Millennium Management
11
Millennium Management
New York
$12K +$2.4K +167 +18%
HF
12
HRT Financial
New York
$11K +$14.1K +982 New
ICM
13
IMS Capital Management
Oregon
$9K – – –
TSS
14
Two Sigma Securities
New York
$8K -$14.6K -1,021 -58%
UBS Group
15
UBS Group
Switzerland
$6K +$7.25K +505 +50,500%
Royal Bank of Canada
16
Royal Bank of Canada
Ontario, Canada
$1K – – –
TRCT
17
Tower Research Capital (TRC)
New York
– -$8K -438 Closed
SWP
18
Stratos Wealth Partners
Ohio
– -$7K -400 Closed
SPIA
19
Steward Partners Investment Advisory
New York
– -$3K -200 Closed
Bank of America
20
Bank of America
North Carolina
– +$43 +3 New

NVIV Hedge Fund Activity: Q4 2021 in Review

19 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in InVivo Therapeutics Holdings Corp (NVIV) for Q4 2021, worth a combined $1.09M — down 18% from $1.32M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new NVIV positions and 3 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.

The largest buyer was Vanguard Group, adding an estimated $148K. The largest seller was Two Sigma Securities, cutting an estimated $14.6K.

  • 19 institutional investors held InVivo Therapeutics Holdings Corp (NVIV) as of Q4 2021, up from 16 in Q3 2021.
  • Funds reported $1.09M of InVivo Therapeutics Holdings Corp stock for Q4 2021, down 18% quarter-over-quarter.
  • 6 funds opened new InVivo Therapeutics Holdings Corp positions in Q4 2021 and 3 closed out, a net change of +3 holders.
  • The largest InVivo Therapeutics Holdings Corp buyer in Q4 2021 was Vanguard Group, an estimated $148K added.
  • The largest InVivo Therapeutics Holdings Corp seller in Q4 2021 was Two Sigma Securities, an estimated $14.6K sold.

Based on aggregated 13F filings for Q4 2021.